{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:27:13Z","timestamp":1793330833469,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA158407"],"award-info":[{"award-number":["R01CA158407"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013678","name":"University of Colorado Cancer Center","doi-asserted-by":"publisher","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100013678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaad.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jaad.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T19:11:42Z","timestamp":1547493102000},"page":"1640-1649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment"],"prefix":"10.1016","volume":"80","author":[{"given":"Makenzie L.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Rioth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Cockburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2019.01.009_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013","volume":"76","author":"Landow","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.01.009_bib2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.27985","article-title":"Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma","volume":"119","author":"Bagaria","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2019.01.009_bib3","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.009_bib4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/A:1011240019516","article-title":"Socioeconomic status and breast cancer incidence in California for different race\/ethnic groups","volume":"12","author":"Yost","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jaad.2019.01.009_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/biomet\/67.1.133","article-title":"Confidence bands for a survival curve from censored data","volume":"67","author":"Hall","year":"1980","journal-title":"Biometrika"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.009_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(15)00482-9","article-title":"Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial","volume":"17","author":"Hayes","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2019.01.009_bib7","author":"National Comprehensive Cancer Network"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.009_bib8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1245\/s10434-016-5646-9","article-title":"Thin melanoma with nodal involvement: analysis of demographic, pathologic, and treatment factors with regard to prognosis","volume":"24","author":"Karakousis","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"50","key":"10.1016\/j.jaad.2019.01.009_bib9","first-page":"87","article-title":"The biology of melanoma prognostic factors","volume":"10","author":"Spatz","year":"2010","journal-title":"Discov Med"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.009_bib10","doi-asserted-by":"crossref","first-page":"e54958","DOI":"10.1371\/journal.pone.0054958","article-title":"Integrative genomics identifies gene signature associated with melanoma ulceration","volume":"8","author":"Rakosy","year":"2013","journal-title":"PLoS One"},{"issue":"35","key":"10.1016\/j.jaad.2019.01.009_bib11","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2019.01.009_bib12","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1245\/s10434-014-3641-6","article-title":"Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor","volume":"21","author":"Mitteldorf","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2019.01.009_bib13","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.jid.2016.05.121","article-title":"Miscoding of melanoma thickness in SEER: research and clinical implications","volume":"136","author":"Gimotty","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.01.009_bib14","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2019.01.009_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2019.01.009_bib16","first-page":"v605","article-title":"LBA7_PR BRIM8: a randomized, double-blind, placebo-controlled study of adjuvant vemurafenib in patients (pts) with completely resected, BRAFV600+ melanoma at high risk for recurrence","volume":"28","author":"Lewis","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219300799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219300799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:38:55Z","timestamp":1565217535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219300799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0190962219300799"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.009","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}